Complement activation in psoriasis.

Area of Science:

• Immunology
• Dermatology
• Complement System Research

Background:

• Psoriasis is a chronic inflammatory skin condition.
• The complement system plays a role in immune responses and inflammation.
• Previous research has suggested potential links between complement activation and psoriasis.

Purpose of the Study:

• To investigate complement activation in patients with psoriasis.
• To quantify specific complement activation fragments (iC3b, C4d, Bb) in psoriasis.
• To correlate fragment levels with psoriasis severity and subtypes.

Main Methods:

• Plasma samples were collected from 16 patients with psoriasis and 12 healthy controls.
• Levels of complement activation fragments (iC3b, C4d, Bb) were measured.
• Patients included those with erythrodermic pustular psoriasis, psoriatic arthritis, and Reiter's syndrome.

Main Results:

• Plasma concentrations of iC3b, C4d, and Bb fragments were significantly higher in psoriasis patients compared to controls.
• Elevated fragment levels were most pronounced in patients with severe forms of psoriasis, including erythrodermic pustular psoriasis, psoriatic arthritis, and Reiter's syndrome.
• Serum concentrations of complement components and regulatory proteins remained normal or elevated, suggesting localized complement activation.

Conclusions:

• The study demonstrates significant complement system activation in psoriasis patients.
• Specific complement fragments (iC3b, C4d, Bb) serve as biomarkers for complement activation in psoriasis.
• Complement activation appears to be a key factor in the pathogenesis of severe psoriasis subtypes.